The company most often compared with Paracor—and its closest competitor--is Acorn Cardiovascular. Such comparisons make sense because the companies are pursuing similar technologies: mechanical devices that wrap around the heart in HF patients to attenuate the progression of heart dilation that causes the organ to grow large and inefficient, unable to pump sufficient amounts of blood. Both companies also hope that their devices can take pressure off the heart to reverse the remodeling process, enabling the organ to heal and get smaller and stronger.
Founded in 1996, three years before Paracor, New Brighton, MN-based Acorn has gone through a series of setbacks that have slowed its product development, including a clinical trial that took...
